In 2025, there were 1,220 babies aborted in Alaska. Roughly 60% of those were taken by the abortion pill. That’s 732 or more unborn children who were lost through the use of abortion pills. That does not include the many instances of women who were harmed by these dangerous drugs.
In a deeply troubling decision, the United States Supreme Court has temporarily allowed the continued mailing of dangerous abortion drugs into pro-life states while litigation proceeds in a landmark Louisiana case challenging the FDA’s reckless deregulation of Mifepristone under the Biden administration.
By a 7-2 vote, the Court granted an emergency appeal from abortion pill manufacturers, preserving Biden-era policies that permit abortion drugs to be shipped by mail without an in-person doctor visit while the case moves forward before the 5th Circuit Court of Appeals. As a result, women can continue receiving dangerous chemical abortion drugs with little or no medical oversight in states that have enacted protections for unborn children following the Supreme Court’s 2022 Dobbs decision, which overturned Roe v. Wade.
While the majority of justices declined to address the merits of the case at this stage, Justices Clarence Thomas and Samuel Alito issued forceful dissents exposing both the legal and moral failures behind the abortion industry’s push for unrestricted mail-order abortion.
Justice Thomas warned that the mailing of abortion drugs likely violates the federal Comstock Act, which prohibits using the mail to distribute drugs intended to produce abortions. Justice Samuel Alito warned that it undermines the Supreme Court’s own ruling in Dobbs v. Jackson Women’s Health Organization, which returned abortion policy decisions to the states and the people.
ALASKA WATCHMAN DIRECT TO YOUR INBOX
According to Alito, abortion pill manufacturers knowingly participate in efforts to circumvent state pro-life laws while continuing to profit from them. Despite repeated claims from the abortion industry that chemical abortion is “safe,” evidence continues to mount showing serious risks associated with mifepristone. The danger only increases when abortion pills are distributed without in-person medical supervision. Without an examination or ultrasound, women may not know how far along they are in pregnancy, whether they have an ectopic pregnancy, or whether they face elevated medical risks.
This fight is far from over. The case now returns to the 5th Circuit Court of Appeals for a full hearing on the merits, and the stakes could not be higher.
Please continue praying for wisdom in our courts, courage for elected leaders, and protection for vulnerable women and children across our nation. And please pray that truth will prevail over political pressure and corporate profit.
The views expressed here are those of the author.
